0002156390-26-000001.txt : 20260921 0002156390-26-000001.hdr.sgml : 20260921 20260921145428 ACCESSION NUMBER: 0002156390-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260921 DATE AS OF CHANGE: 20260921 EFFECTIVENESS DATE: 20260921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Typewriter Therapeutics, Inc. CENTRAL INDEX KEY: 0002156390 ORGANIZATION NAME: EIN: 880705807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598263 FILM NUMBER: 261393535 BUSINESS ADDRESS: STREET 1: 238 MAIN STREET, OFFICE 2162 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 609-923-9289 MAIL ADDRESS: STREET 1: 238 MAIN STREET, OFFICE 2162 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0002156390 Typewriter Therapeutics, Inc. 238 MAIN STREET, OFFICE 2162 CAMBRIDGE MA MASSACHUSETTS 02142 609-923-9289 DELAWARE None None Corporation true 2022 Matthew Stanton 238 Main Street, Office 2162 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Kenneth Horne 238 Main Street, Office 2162 Cambridge MA MASSACHUSETTS 02142 Director Laura Tadvalkar 238 Main Street, Office 2162 Cambridge MA MASSACHUSETTS 02142 Director Mikael Dolston 238 Main Street, Office 2162 Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2026-01-08 false true false 0 56299999 56299999 0 false 6 0 0 0 false Typewriter Therapeutics, Inc. Matthew Stanton Matthew Stanton CEO 2026-09-11